• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Topics » General Psychiatry

General Psychiatry
General Psychiatry RSS Feed RSS

What You Need to Know About Gepirone (Exxua) _ Benefits, Side Effects, and Review of Trials_Thumb.jpg

What You Need to Know About Gepirone (Exxua) | Benefits, Side Effects, and Review of Trials

September 27, 2024
Chris Aiken, MD. and Greg Malzberg, MD
In this video, Dr. Chris Aiken, Editor-in-Chief of The Carlat Psychiatry Report, provides a comprehensive review of Gepirone, also known as Exxua, a newly FDA-approved antidepressant for major depressive disorder in adults. Gepirone is unique due to its classification as an azipirone, a class of medications that work as serotonin 5-HT1A receptor agonists. 
Read More

CME Post-Test, Addiction, TCPR, October 2024

September 26, 2024
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

By successfully completing the test you will be awarded a certificate for 1 CME credit.


Read More
Research Update

Enhancing PTSD Therapy With Aerobic Exercise: A New Approach

September 26, 2024
José S. Sanchez-Cruz, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

José S. Sanchez-Cruz, MD. Dr. Sanchez-Cruz has no financial relationships with companies related to this material.

Exercise improves sleep, cognition, and hippocampal volume, but can it enhance exposure-based learning in therapy for PTSD?


Read More
Clinical Update

Unraveling Post-SSRI Sexual Dysfunction

September 26, 2024
Awais Aftab, MD.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Awais Aftab, MD. Psychiatrist in Cleveland, Ohio, and Clinical Assistant Professor of Psychiatry at Case Western Reserve University. Author of the online newsletter Psychiatry at the Margins.

Dr. Aftab has no financial relationships with companies related to this material.

Patient advocacy groups are adamant that it exists. European regulators have given it the stamp of approval. Here, we look at the evidence that sexual dysfunction can persist long after stopping an SSRI.


Read More
TCPR-Oct2024_QA_NCapurso headshot.png
Clinical Update

A New Era for Buprenorphine

September 26, 2024
Noah Capurso, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

TCPR-Oct2024_QA_NCapurso headshot.pngNoah Capurso, MD, MHS.

Associate Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.

Dr. Capurso has no financial relationships with companies related to this material.

A buprenorphine boot camp for all who need to know how to use it in the post-X-waiver age.


Read More
Clinical Update

Post X-Waiver Buprenorphine Prescribing

September 26, 2024
Noah Capurso, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Noah Capurso, MD, MHS. Associate Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.

Dr. Capurso has no financial relationships with companies related to this material.

All clinicians need to know how to use buprenorphine under the DEAs new regulations. Meanwhile, the fentanyl crisis is changing how we use it. Noah Capurso shows us how to navigate these waters.


Read More
shutterstock_2518443749.jpg

PTSD 101: Nine Off-Label Meds

September 23, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

A new medication is knocking on the door for FDA approval in PTSD, and it isn’t MDMA. We cover that, and 8 other off label medications.


Read More
Stimulant_Dosing_Thumb.jpg

Stimulant Dosing Limits for ADHD: When Is The Adderall / Ritalin Dose Too High?

September 18, 2024
Chris Aiken, MD., Kelvin Quiñones-Laracuente, MD, PhD, and Greg Malzberg, MD
 In this video, we aim to break down where the safe upper limits lie for stimulant dosing, what to consider when increasing doses, and why crossing certain thresholds can lead to serious risks. We start by discussing why increasing stimulant doses beyond a certain point can be dangerous.
Read More
shutterstock_385842823.jpg

PTSD 101: Prazosin or SSRI?

September 17, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

Should we follow the FDA and give SSRIs, or venture off-label with the fabled prazosin?


Read More
CarlatPsychEp1.png
CARLAT WEBINAR

Carlat Psychiatry News - Stimulant Fraud • Oral Ketamine • E-Cigarettes • Benzo Tapering • CBD

September 17, 2024
Chris Aiken, MD, Greg Malzberg, MD, and Kellie Newsome, PMHNP

0.25 CME Credits. In this episode, we explore nine groundbreaking stories in mental health and psychiatric medicine, covering everything from healthcare fraud to the latest advancements in drug trials. First, we dive into the recent charges brought by the US Department of Justice against executives at Done, a California-based telehealth company, for alleged healthcare fraud. Done is accused of prescribing over 40 million Adderall pills to patients without proper evaluation, raising concerns about the balance between increasing mental healthcare access and responsible prescribing practices.


Read More
Previous 1 2 … 5 6 7 8 9 10 11 12 13 … 176 177 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB7e_Print_App_Access.png

    Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

    The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2637648401.jpg
    General Psychiatry

    Psychopharm Secrets: Coming Off Meds

    There’s a hidden placebo response to watch for when patients stop meds on their own.
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.